0.85Open0.85Pre Close0 Volume3 Open Interest30.00Strike Price0.00Turnover241.14%IV32.16%PremiumMay 16, 2025Expiry Date0.00Intrinsic Value100Multiplier7DDays to Expiry0.85Extrinsic Value100Contract SizeAmericanOptions Type-0.1065Delta0.0128Gamma50.55Leverage Ratio-0.1864Theta-0.0010Rho-5.38Eff Leverage0.0109Vega
Protagonist Therapeutics Stock Discussion
Major Clinical Breakthrough: Rusfertide Phase 3 PV Treatment Data Earns Coveted ASCO Plenary Spot
Revolutionary Once-Daily Pill Achieves Complete Skin Clearance in 75% of Teen Psoriasis Patients
Protagonist Reports Positive Top Line Results From Phase 2b Study of Icotrokinra Showing Potential to Transform the Treatment Paradigm for Patients With Ulcerative Colitis
Can This New Oral Psoriasis Drug Replace Injectable Treatments? Phase 3 Data Shows Remarkable 46% Complete Clearance
Can This New Drug Cut Blood Draws by 72% for Polycythemia Vera Patients?
Just my thoughts and where I plan to put my money in. $Texas Pacific Land (TPL.US)$, $Arista Networks (ANET.US)$, $Protagonist Therapeutics (PTGX.US)$ , $Tesla (TSLA.US)$ in my play lists tomorrow. The first two have earnings coming up this week as well.
Play safe, make a lot of money Mooers, either side up or down!
No comment yet